Tonal Funding: $580M Raised, Series E (2023)

Tonal funding overview

Tonal is a Healthtech company based in San Francisco. Tonal has raised $580M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series E announced in April 2023. The round record for Tonal runs through 2023; nothing later has been disclosed. Investors on record include Dragoneer Investment Group, SoftBank Vision Fund, General Catalyst, Khosla Ventures, L Catterton, Cobalt Capital and 8 others. 14 distinct backers are named across the disclosed rounds.

Tonal at a glance

Total raised: $580M
Latest round: Series E
Latest round date: April 2023
Industry: Healthtech
Headquarters: San Francisco
Notable investors: Dragoneer Investment Group, SoftBank Vision Fund, General Catalyst, Khosla Ventures, L Catterton, Cobalt Capital, Kindred Ventures, THVC

Frequently asked about Tonal funding

How much has Tonal raised?: Tonal has raised $580M in total disclosed funding across the rounds on record.
Who has invested in Tonal?: Dragoneer Investment Group, SoftBank Vision Fund, General Catalyst, Khosla Ventures, L Catterton, Cobalt Capital are named among the investors backing Tonal.
What was the latest Tonal funding round?: The most recent disclosed round is a Series E, announced in April 2023.
Where is Tonal based?: Tonal is based in San Francisco.
What sector does Tonal operate in?: Tonal is tracked under Healthtech from San Francisco, with $580M in disclosed funding.
When did Tonal last raise?: The last disclosed Tonal round closed in April 2023 at Series E.

Tonal totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Healthtech companies in San Francisco below to benchmark round size and investor mix.

Tonal Funding: $580M Raised, Series E (2023)

Tonal funding overview

Tonal at a glance

Frequently asked about Tonal funding

Companies related to Tonal (40)

Browse related funding lists (9)